Determination of nevirapine in plasma by GC-MS

Journal of Chromatographic Science

Volumn 48, Issue 2, 2010, Pages 91-94

  Vogel, M ^a   Bertram, N ^b   Wasmuth, J C ^a   Emmelkamp, J ^a   Rockstroh, J K ^a   Reichel, C ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Laboratory for Toxicology and Analytics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75849150764     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.2.91     Document Type: Article

References (19)

1. L. Waters, L. John and M. Nelson. Non-nucleoside reverse transcriptase inhibitors: a review. Int. J. Clin Pract. (61): 105-118 (2007).
2. A. Milinkovic and E. Martinez. Nevirapine in the treatment of HIV. Expert Rev Anti. Infect. Ther. (2): 367-73 (2004).
3. D. Gonzalez de Requena S. Bonora, S. Garazzino, M. Sciandra, A. D'Avolio, R. Raiteri, R. Marrone, M. Boffito, F.G. De Rosa, A. Sinicco, and G. Di Perri. Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting. Antimicrob. Agents Chemother. (49): 3966-3969 (2005).
4. C. Torti, G. Lapadula, M.C. Uccelli, E. Quiros-Roldan, M. Regazzi, N. Ladisa, V. Micheli, A. Orani, A. Patroni, S.L. Caputo, V. Tirelli, S. Di Giambenedetto, G. Cologni, S. Costarelli, F. Gargiulo, N. Manca, and G. Carosi. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. Int. J. Antimicrob. Agents. (29): 185-190 (2007).
5. L. Aranzabal, J.L. Casado, J. Moya, C. Quereda, S. Diz, A. Moreno, L. Moreno, A. Antela, M.J. Perez-Elias, F. Dronda, A. Marin, F. Hernandez-Ranz, and S. Moreno. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin. Infect Dis. (40): 588-593 (2005).
6. M. Boffito, E. Acosta, D. Burger, C.V. Fletcher, C. Flexner, R. Garaffo, G. Gatti, M. Kurowski, C.F. Perno, G. Peytavin, M. Regazzi, and D. Back. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs. Antivir Ther. (10): 469-477 (2005).
7. R.E. Aarnoutse, J.M. Schapiro, C.A. Boucher, Y.A. Hekster, and D.M. Burger. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs? Drugs. (63): 741-753 (2003).
8. E. Dailly, L. Thomas, M.F. Kergueris, P. Jolliet, and M. Bourin. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction. J. Chromatogr. B Biomed. Sci. Appl. (758): 129-135 (2001).
9. P. Villani, M. Feroggio, L. Gianelli, A. Bartoli, M. Montagna, R. Maserati, and M.B. Regazzi. Antiretrovirals: simultaneous deter-mination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay. Ther Drug Monit. (23): 380-388 (2001).
10. V.A. Simon, M.D. Thiam, and L.C. Lipford. Determination of serum levels of thirteen human immuno deficiency virus-suppressing drugs by high-performance liquid chromatography. J. Chromatogr. A (913): 447-453 (2001).
11. R.M. Lopez, L. Pou, M.R. Gomez, I. Ruiz, and J. Monterde. Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. (751): 371-376 (2001).
12. G. Aymard, M. Legrand, N. Trichereau, and B. Diquet. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatog-raphy. J. Chromatogr. B Biomed. Sci. Appl. (744): 227-240 (2000).
13. R.M. Hollanders, E.W. van Ewijk-Beneken Kolmer, D.M. Burger, E.W. Wuis, P.P. Koopmans, and Y.A. Hekster. Determination of nevi-rapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. (744): 65-71 (2000).
14. T.L. Laurito, V. Santagada, G. Caliendo, C.H. Oliveira, R.E. Barrientos-Astigarraga, and G. De Nucci. Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J. Mass Spectrom. (37): 434-441 (2002).
15. J. Chi, A.L. Jayewardene, J.A. Stone, and F.T. Aweeka. AnLC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma. J. Pharm. Biomed Anal. (31): 953-959 (2003).
16. K.M. Rentsch. Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. (788): 339-350 (2003).
17. R. ter Heine, C.G. Alderden-Los, H. Rosing, M.J. Hillebrand, E.C. van Gorp, A.D. Huitema, and J.H. Beijnen. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Comm. Mass Spectrom. (21): 2505-2514 (2007).
18. H.N. Mistri, A.G. Jangid, A. Pudage, N. Gomes, M. Sanyal, and P. Shrivastav. High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. (853): 320-332 (2007).
19. Z. Liu, P. Fan-Havard, Z. Xie, C. Ren, and K.K. Chan. A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2-hydroxynevirapine and nevirapine 4-carboxylic acid, and pharmacokinetics in baboons. Rapid Commun Mass Spectrom. (21): 2734-2742 (2007).